Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameZyloxtb
Stock Code02190
Company Full NameTo be extracted
IndustryHealthcare
Principal Activities我們是中國神經和外周血管介入醫療器械市場的領導者,為中國及海外的醫生和患者提供治療及應對神經和外周血管疾病的醫療器械,涵蓋急性缺血性腦卒中、顱內動脈瘤、頸動脈狹窄、外周動脈和靜脈疾病及透析相關疾病。
Listing Date2021-07-05
Listing Rules EraOld Rules
Listing Rules Chapter18A生物科技
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國浙江省杭州市余杭區科技大道18號1幢1、2層
Business Address (Hong Kong)香港灣仔皇后大道東248號大新金融中心40層
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitezyloxtb.com
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism A
Offer PriceHK$ 42.70 / shares
Offer Price RangeFinal offer price only, no range
Lot Size500 shares
Entry ThresholdHK$ 21,350
Par ValueRMB 1.0 / shares
Offer Period2021-06-22 to 2021-06-25
Global Offering Shares60,000,000 shares
HK Public Offer Shares (Initial)6,000,000 shares (10.0%)
Public Offer Lots (Initial)12,000lots (Pool A6,000lots,Pool B6,000lots)
International Placing Shares (Initial)54,000,000 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO323,401,001 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)To be extracted
Cornerstone Share43.9%
Clawback TiersTo be extracted
Reallocation OptionYes
Total Global Offering SizeHK$ 2,562,000,000

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 500 HK$ 21,350
2 lots 1,000 HK$ 42,700
3 lots 1,500 HK$ 64,050
4 lots 2,000 HK$ 85,400
5 lots 2,500 HK$ 106,750
6 lots 3,000 HK$ 128,100
7 lots 3,500 HK$ 149,450
8 lots 4,000 HK$ 170,800
9 lots 4,500 HK$ 192,150
10 lots 5,000 HK$ 213,500
12 lots 6,000 HK$ 256,200
14 lots 7,000 HK$ 298,900
16 lots 8,000 HK$ 341,600
18 lots 9,000 HK$ 384,300
20 lots 10,000 HK$ 427,000
30 lots 15,000 HK$ 640,500
40 lots 20,000 HK$ 854,000
50 lots 25,000 HK$ 1,067,500
60 lots 30,000 HK$ 1,281,000
70 lots 35,000 HK$ 1,494,500
80 lots 40,000 HK$ 1,708,000
90 lots 45,000 HK$ 1,921,500
100 lots 50,000 HK$ 2,135,000
120 lots 60,000 HK$ 2,562,000
140 lots 70,000 HK$ 2,989,000
160 lots 80,000 HK$ 3,416,000
180 lots 90,000 HK$ 3,843,000
200 lots 100,000 HK$ 4,270,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
400 lots 200,000 HK$ 8,540,000
600 lots 300,000 HK$ 12,810,000
800 lots 400,000 HK$ 17,080,000
1,000 lots 500,000 HK$ 21,350,000
1,200 lots 600,000 HK$ 25,620,000
1,400 lots 700,000 HK$ 29,890,000
1,600 lots 800,000 HK$ 34,160,000
1,800 lots 900,000 HK$ 38,430,000
2,000 lots 1,000,000 HK$ 42,700,000
4,000 lots 2,000,000 HK$ 85,400,000
6,000 lots 3,000,000 HK$ 128,100,000

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
HK Market Cap HK$ 6.74B
Est. Threshold HK$ 9.44B
Analysis Result HK market cap below threshold, need +40%

Valuation & Financials

Market Cap (at Offer Price)HK$ 13,809,222,742
H-Share Market Cap (at Offer Price)HK$ 5,188,903,914
Pre-IPO Valuation (Last Round)Not disclosed
P/E Ratio不適用(公司處於虧損狀態)
Profit/Loss Status虧損人民幣100.5百萬元
Period-End Cash BalanceTo be extracted
Listing Expenses~HK$ 161,000,000
Listing Expenses / Funds Raised~6.28%
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: '000 RMB
Income Statement
Item 20192020
Revenue 4,91727,631
Cost of sales -3,725-11,344
Gross profit 1,19216,287
Other income and gains, net 7,6569,997
Selling and distribution expenses -6,759-20,453
Administrative expenses -16,962-30,992
Operating profit -65,701-100,162
Net finance costs -946-306
Profit before tax -66,647-100,468
Income tax expense 00
Profit for the year -66,647-100,468
Profit attributable to owners -66,647-100,468
Balance Sheet
Item 20192020
Cash and cash equivalents 46,13059,556
Trade and bills receivables 1,013129
Inventories 9,95528,993
Total current assets 125,284370,142
Total assets 207,060503,971
Total current liabilities 33,38751,631
Total liabilities 41,38579,277
Total equity 165,675424,694
Equity attributable to owners 165,675424,694
Interest-bearing borrowings 17,50030,000
Cash Flow Statement
Item 20192020
Net cash from operating activities -53,092-82,334
Net cash from investing activities -90,593-249,176
Net cash from financing activities 179,444345,537
Net increase in cash 35,75914,027
Purchase of PP&E -41,582-45,140
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 60.0
First Day OpenHK$ 55.0
First Day Change40.52%
First Day Volume58971000.0
First Day Turnover3342110000.0
Use of Proceeds
1、約37.0%,或888.1百萬港元,將被分配予我們的核心產品; 2、約11.0%,或262.2百萬港元,將被分配予我們其他5款主要產品的持續研發、生產及商業化; 3、約40.0%,或959.5百萬港元,將被分配予我們其他38款產品及在研管線,以開發我們的產品組合,進而提供全線解決方案; 4、約3.0%,或71.9百萬港元,將分配予進一步升級研發設施,包括位于杭州及珠海的軟件及硬件基礎設施,以及在珠海計劃進行的辦公室擴建與升級; 5、約4.0%,或95.9百萬港元,將分配予潛在戰略收購、投資、授權引進或合作; 6、約5.0%,或119.9百萬港元,將用于我們的營運資金及一般公司用途。

Underwriting Syndicate

Joint Sponsors (2)
Morgan Stanley Asia Limited CE AAD291 中信证券(香港)有限公司 CE AAK249
Overall Coordinators (6)
Morgan Stanley Asia Limited CE AAD291 中信里昂证券有限公司 CE AAB893 CHINA INDUSTRIAL SECURITIES INTERNATIONAL CAPITAL LIMITED CE BAK956 SDIC SECURITIES (HONG KONG) LIMITED CE AUW685 ICBC INTERNATIONAL SECURITIES LIMITED CE ARO299 招银国际融资有限公司 CE AVM940
Joint Bookrunners (6)
Morgan Stanley Asia Limited CE AAD291 中信里昂证券有限公司 CE AAB893 CHINA INDUSTRIAL SECURITIES INTERNATIONAL CAPITAL LIMITED CE BAK956 SDIC SECURITIES (HONG KONG) LIMITED CE AUW685 ICBC INTERNATIONAL SECURITIES LIMITED CE ARO299 招银国际融资有限公司 CE AVM940
Joint Lead Managers (6)
Morgan Stanley Asia Limited CE AAD291 中信里昂证券有限公司 CE AAB893 CHINA INDUSTRIAL SECURITIES INTERNATIONAL CAPITAL LIMITED CE BAK956 SDIC SECURITIES (HONG KONG) LIMITED CE AUW685 ICBC INTERNATIONAL SECURITIES LIMITED CE ARO299 招银国际融资有限公司 CE AVM940

Cornerstone Investors

#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 AIHC Master Fund 124,192,950 HKD — 4.85% — 6 months 2022-01-05
2 Athos Asia Event Driven Master Fund 31,042,900 HKD — 1.21% — 6 months 2022-01-05
3 Boyu Capital Opportunities Master Fund 124,192,950 HKD — 4.85% — 6 months 2022-01-05
4 Cormorant Asset Management, LP 62,085,800 HKD — 2.42% — 6 months 2022-01-05
5 Fidelity International 155,235,850 HKD — 6.06% — 6 months 2022-01-05
6 Hillhouse Funds 232,843,100 HKD — 9.09% — 6 months 2022-01-05
7 Hudson Bay Master Fund LTD 77,607,250 HKD — 3.03% — 6 months 2022-01-05
8 Lake Bleu Prime Healthcare Master Fund Limited 155,235,850 HKD — 6.06% — 6 months 2022-01-05
9 Octagon Investments Master Fund LP 54,314,400 HKD — 2.12% — 6 months 2022-01-05
10 Sage Partners Master Fund 15,521,450 HKD — 0.61% — 6 months 2022-01-05
11 Snow Lake China Master Fund, Ltd. 77,607,250 HKD — 3.03% — 6 months 2022-01-05
12 常春藤资产管理(香港)有限公司 15,521,450 HKD — 0.61% — 6 months 2022-01-05

Directors & Management

PositionChinese nameEnglish Name
ChairmanJonathon Zhong Zhao—
Company Secretary袁泉衛、張啟昌—
No director data available.

Major Shareholders

Major Shareholders & Holdings趙博士及其一致行動人士(包括鐘博士、李博士、衛女士、珠海通橋投資、杭州涪江、珠海歸創、湖州歸橋、WEA及南京語意慧)緊接全球發售前合共持有約36.55%權益;王暉先生及其弘暉股東合共持有約11.11%權益;OAP IV (HK) Limited持有約7.83%、先進製造產業投資基金持有約6.33%、清池資本持有約4.67%、AIHC Master Fund持有約3.86%。
About this page

This page shows Zyloxtb (02190) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect